Companies: 10,795·Total market cap: $144.5T
Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc.

APGENASDAQHealthcare● Active
$83.01
$-3.91(-4.50%)
Market Cap$5.1B
P/E Ratio
52W High$95.315
52W Low$34.34
Overview

Apogee Therapeutics, Inc. (APGE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · APGE · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.33apge eps ttm · apge earnings per shareEarnings history
PE Ratio (TTM)apge pe ratio ttm · apge price to earningsPE Ratio deep dive
Revenue (TTM)0.00apge revenue ttm · apge annual revenueFull revenue history
Dividend YieldNo Dividenddoes apge pay dividends · apge dividend yieldDividend history
Shares Outstanding60.7Mapge shares outstanding · apge floatShares outstanding history
Next EarningsAug 10, 2026Est.apge earnings date · apge next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
apogee therapeutics, inc. revenue · apge revenue 2025
FY 2025Net Income-$255.8M▼ 40.46% YoY
202320242025
apogee therapeutics, inc. net income · apge profit 2025
FY 2025EPS$-4.22▼ 27.88% YoY
202320242025
apge eps · apogee therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$274.6MEPS: $-4.33View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis apge a buy · apge analyst rating
Strong Buy
0
Buy
9
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$81.00Low
$83.01Current
$111.00Avg Target33.72% upside
$140.00High
apge price target · apge 12 month forecast

Total: 11 · Buy rate: 81.8%

The APGE analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $111.00, representing +33.72% upside from the current price of $83.01.

Stock Performance

Full History
1D-4.38%
1W+10.43%
1M+4.69%
3M+18.99%
YTD+15.16%
1Y+116.60%
5Y+309.42%

About Apogee Therapeutics, Inc.

CEOMichael Thomas Henderson
IPO DateJul 14, 2023
Employees196
CountryUS

Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary…

what is apogee therapeutics, inc. · apge stock overview · apogee therapeutics, inc. company profile · who is apogee therapeutics, inc. ceo · apge NASDAQ · apogee therapeutics, inc. headquarters · apogee therapeutics, inc. business segments

About Stock Overview & Key Data

Apogee Therapeutics, Inc. (APGE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 14, 2023. As of the latest trading session, APGE stock price is $83.01, with a market capitalization of $5.1B. The stock has returned +116.60% over the past 12 months and +15.16% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Apogee Therapeutics, Inc. stock is Buy, with an average 12-month price target of $111.00. In fiscal year 2025, Apogee Therapeutics, Inc. reported revenue of — and net income of -$255.8M. For detailed data — including Apogee Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Apogee Therapeutics, Inc. (APGE) stock price is $83.01. The stock is traded on NASDAQ under the ticker symbol APGE. The 52-week range is $34.34 – $95.31.

APGE stock priceAPGE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice